Brief: Adaptive Biotechnologies Q4 EPS USD -0.23
11/02/2025 21:05
Feb 11 (Reuters) - Adaptive Biotechnologies Q4 operating income USD -33.837 million vs. IBES estimate USD -37.8 million. * Q4 revenue USD 47.459 million vs. IBES estimate USD 46 million * Q4 operating expenses USD 81.296 million * Q4 net income USD -33.717 million vs. IBES estimate USD -38.9 million * Q4 adjusted EBITDA USD -16.4 million vs. IBES estimate USD -21.1 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile